Idera Pharmaceuticals, Inc.
IDRA · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21,867 | -$10,776 | -$3,099 | -$5,307 |
| Dep. & Amort. | $3 | $4 | $3 | $4 |
| Deferred Tax | -$273 | $6,039 | -$6,039 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$1,821 | -$5,853 | $5,620 | $1,194 |
| Other Non-Cash | $12,875 | -$3,288 | -$94 | $22 |
| Operating Cash Flow | -$9,852 | -$13,204 | -$3,198 | -$3,525 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $5,482 | $0 |
| Investing Cash Flow | $0 | $0 | $5,482 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $15 | -$81 | $66 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$74 | -$1,547 | $31 | $12 |
| Financing Cash Flow | -$74 | -$1,547 | $31 | $12 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$9,926 | -$14,751 | $2,315 | -$3,513 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,044 | $26,795 | $24,480 | $27,993 |
| End Cash | $2,118 | $12,044 | $26,795 | $24,480 |
| Free Cash Flow | -$9,852 | -$13,204 | -$3,198 | -$3,525 |